Mechanisms and models in heart failure: A combinatorial approach.
about
Microtissues in Cardiovascular Medicine: Regenerative Potential Based on a 3D MicroenvironmentCell Therapy in Ischemic Heart Disease: Interventions That Modulate Cardiac RegenerationAnimal Models and "Omics" Technologies for Identification of Novel Biomarkers and Drug Targets to Prevent Heart FailurePreclinical stem cell therapy in Chagas Disease: Perspectives for future researchCholinergic activity as a new target in diseases of the heartVenous congestion, endothelial and neurohormonal activation in acute decompensated heart failure: cause or effect?The role of iNOS-derived NO in the antihypertrophic actions of B-type natriuretic peptide in neonatal rat cardiomyocytesCardiomyopathy in α-kinase 3 (ALPK3)-deficient miceAttenuation of cardiac remodeling after myocardial infarction by muscle LIM protein-calcineurin signaling at the sarcomeric Z-discHydrochlorothiazide modulates ischemic heart failure-induced cardiac remodeling via inhibiting angiotensin II type 1 receptor pathway in rats.Serial MRI evaluation of cardiac structure and function in mice after reperfused myocardial infarction.Generation and Assessment of Functional Biomaterial Scaffolds for Applications in Cardiovascular Tissue Engineering and Regenerative MedicineSerial ultrasound evaluation of intramyocardial strain after reperfused myocardial infarction reveals that remote zone dyssynchrony develops in concert with left ventricular remodeling.Mechanisms of Post-Infarct Left Ventricular RemodelingThe gene expression fingerprint of human heart failure.Role of echocardiography in diagnosis and risk stratification in heart failure with left ventricular systolic dysfunction.Impaired mitochondrial network excitability in failing guinea-pig cardiomyocytesNew competition in the realm of renin-angiotensin axis inhibition; the angiotensin II receptor antagonists in congestive heart failure.Role of myofibrillogenesis regulator-1 in myocardial hypertrophy.Granulocyte colony-stimulating factor protects cardiac mitochondria in the early phase of cardiac injury.Phosphorylation of TRPC6 channels at Thr69 is required for anti-hypertrophic effects of phosphodiesterase 5 inhibitionFGF-2 controls the differentiation of resident cardiac precursors into functional cardiomyocytes.Pain and heart failure: unrecognized and untreated.Facts and principles learned at the 31st Annual Williamsburg Conference on Heart Disease.Injectable hydrogel properties influence infarct expansion and extent of postinfarction left ventricular remodeling in an ovine modelDASH eating pattern is associated with favorable left ventricular function in the multi-ethnic study of atherosclerosis.Regional left ventricular myocardial dysfunction as a predictor of incident cardiovascular events MESA (multi-ethnic study of atherosclerosis).N-terminal pro-B-type natriuretic peptide, left ventricular mass, and incident heart failure: Multi-Ethnic Study of AtherosclerosisInhibition of calcineurin-NFAT hypertrophy signaling by cGMP-dependent protein kinase type I in cardiac myocytes.beta-blockers in heart failure: recently completed and ongoing clinical trials.Evolution and pathophysiology of chronic systolic heart failure.Triiodothyronine and brain natriuretic peptide: similar long-term prognostic values for chronic heart failure.Mitral ring annuloplasty: an incomplete correction of functional mitral regurgitation associated with left ventricular remodeling.Innate immune response after acute myocardial infarction and pharmacomodulatory action of tacrolimus in reducing infarct size and preserving myocardial integrity.Increased levels of inflammatory cytokines and endothelin-1 in alveolar macrophages from patients with chronic heart failure.Skeletal muscle disorders in heart failure.B-type natriuretic peptide: the level and the drug--partners in the diagnosis of congestive heart failure.A glossary of circulating cytokines in chronic heart failure.Allograftic bone marrow-derived mesenchymal stem cells transplanted into heart infarcted model of rabbit to renovate infarcted heart.Pharmacotherapy in congestive heart failure: diuretic resistance and strategies to overcome resistance in patients with congestive heart failure.
P2860
Q26748747-AC5668E4-9B3D-4C58-8F17-A07159087259Q26765916-F99C3DCB-2478-4237-961D-EEDBB74D13F9Q26799838-1E588FC0-D739-4C33-9898-9D2AD3A31C60Q26866266-9DDA30F6-D565-4F8C-AE30-CC662C4DB927Q27004543-C27225BE-5020-48C3-B045-7E530FDE3873Q28088361-755C587A-2CBF-4CB3-A236-6B70A02C6A2BQ28583344-24952F5F-0F82-4956-990A-B5D110A52076Q28589708-873FE154-0A33-4C52-A570-FD08DC24B9E2Q28593396-C2B765D6-3783-46F7-9D1B-52A71B6B618BQ30275124-20DD8505-8B83-4D65-9AF7-E7120E9CEF41Q30309628-C0D89F33-467C-4D20-94E1-95223CE32E32Q30390768-4D7979B8-6F24-4CF0-A290-B9AC4FEB4FFBQ30426335-FB805FC1-C447-4A40-B2C9-8CABBADA2D3FQ30441277-65B985FE-6D32-4D47-9F5E-34B942ACC276Q30476199-D9243A46-EB12-469C-8914-9CB92E4DC70EQ30500004-D461E55F-5B10-4468-9DCD-EBC09917A372Q30692654-3818EAE2-742E-4352-892E-83270219ADD8Q31989723-446177AD-9095-4272-A624-117FC6823E1BQ33221703-3F202637-1899-4F89-8DBA-06674AF74E32Q33399024-B1F9CA1C-21FA-483E-AF7B-0F802B546517Q33799926-818EC1E5-C7CA-4E61-83AC-8B0565A5CF8DQ33842934-9DA6EF17-356F-4DF4-9E1F-7D381469FD8BQ33900159-C97EB912-618F-4659-B0FA-1AB4904A7C95Q33944878-C9B5F16F-B2DD-4BA1-91F0-32D9C8C3D548Q33953399-1B19F631-0359-4854-B99D-3498CE92ED58Q33993428-329F1DF5-ADF8-48AE-88AF-286CEABFF24BQ34014145-380860D5-14FE-4DDA-BA02-1F813FC6E83FQ34014190-995E3251-88E7-42D0-8F45-8730E76CBF35Q34038333-3707B80B-C5C1-4357-AEDC-392BB4F295E0Q34074729-C000C26E-E271-4363-A4D0-A93CFDAE6F41Q34088198-0EB4268B-6D08-4862-B0D5-3398D336B5ABQ34190826-0237B8B7-C3FD-4780-8DDE-8EDA01D77A0BQ34221067-9580D501-98F2-499E-8095-F96991DA0192Q34242699-188C8571-4429-4E4E-9A54-57101C3045D9Q34277432-E86CE06A-9952-4F6D-BCA9-6F38967559EFQ34285823-C3F75638-3F7F-453B-B79A-82E1167CF68CQ34297057-3CF4BAC2-3BFE-4D38-8067-B1141E37EB5FQ34398220-9A94DBAA-5718-4479-A2F7-E6A76324F2F5Q34423210-0E620E84-5F8D-48DC-9311-B2A3AD242BF1Q34584204-2A069437-D16E-4CCF-9EF1-6780EFC34B8E
P2860
Mechanisms and models in heart failure: A combinatorial approach.
description
1999 nî lūn-bûn
@nan
1999 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Mechanisms and models in heart failure: A combinatorial approach.
@ast
Mechanisms and models in heart failure: A combinatorial approach.
@en
type
label
Mechanisms and models in heart failure: A combinatorial approach.
@ast
Mechanisms and models in heart failure: A combinatorial approach.
@en
prefLabel
Mechanisms and models in heart failure: A combinatorial approach.
@ast
Mechanisms and models in heart failure: A combinatorial approach.
@en
P356
P1433
P1476
Mechanisms and models in heart failure: A combinatorial approach.
@en
P2093
P304
P356
10.1161/01.CIR.100.9.999
P407
P577
1999-08-01T00:00:00Z